Anticancer Drugs Course
This course equips oncology professionals with practical knowledge on first-line EGFR TKI treatments for EGFR-mutated NSCLC. Participants will master drug selection, toxicity management, resistance handling, monitoring, and patient communication to deliver evidence-based care and improve patient outcomes effectively.

flexible workload of 4 to 360h
valid certificate in your country
What will I learn?
Gain practical insights into first-line systemic treatments for EGFR-mutated NSCLC, covering targeted therapies, chemo-immunotherapy, and chemotherapy. Understand drug mechanisms, dosing schedules, toxicity profiles, prevention strategies, resistance mechanisms, second-line therapies, monitoring protocols, and effective patient communication for informed clinical decisions.
Elevify advantages
Develop skills
- Select EGFR TKI regimens for first-line treatment using latest trial data.
- Plan imaging, re-biopsy, and liquid biopsy to assess resistance.
- Match resistance mechanisms to targeted therapy, chemotherapy, or trials.
- Prevent and manage side effects like rash, diarrhoea, ILD, and low blood counts.
- Counsel patients clearly on treatment goals, side effects, and next steps.
Suggested summary
Before starting, you can change the chapters and the workload. Choose which chapter to start with. Add or remove chapters. Increase or decrease the course workload.What our students say
FAQs
Who is Elevify? How does it work?
Do the courses have certificates?
Are the courses free?
What is the course workload?
What are the courses like?
How do the courses work?
What is the duration of the courses?
What is the cost or price of the courses?
What is an EAD or online course and how does it work?
PDF Course